Meeting reports

2012

• Global forecasts of antiretroviral demand 2012-2015
  Joint WHO/UNAIDS consultation with pharmaceutical companies and stakeholders
  13 November 2012
• WHO informal consultation on medium- and long-term priorities for ARV drug optimization
  Moving towards simplification, harmonization and universal access
  1 October 2012
• Short, medium and long term product development priorities in HIV-related diagnostics
  WHO expert meeting report (6-7 June 2012, Geneva, Switzerland)
  1 October 2012
• Report of the meeting of the paediatric working group developing an optimized list of paediatric ARV formulations
  Interagency Task Team on prevention and treatment of HIV infection in pregnant women, mothers and their children (5 May 2011, Switzerland)
  1 September 2012
• Framework for metrics to support effective treatment as prevention
  Meeting report (2-3 April 2012, Geneva, Switzerland)
  1 September 2012
• Developing dosing guidance for new and upcoming formulations of paediatric ARVs in line with Treatment 2.0 priorities
  Report of the meeting of the Antiretroviral Working Group (25-26 October 2011)
  1 August 2012
• Assessment of WHO HIV drug resistance early warning indicators
  Report of the Early Advisory Indicator Panel meeting (11-12 August 2011)
  1 July 2012
• Report on WHO ResNet Annual Meeting
  Bill and Melinda Gates Foundation (4 March 2012)
  1 July 2012
• Annual stakeholders and partners meeting: AIDS medicines and diagnostics service
  Meeting report: 18-19 June 2012, Switzerland
  19 June 2012
• WHO-NIH Informal consultation on antiretroviral treatment as HIV prevention: Implementation science in Asia
  Meeting report (26-28 March 2012, Siem Reap, Cambodia)
  1 June 2012
• The strategic use of antiretrovirals for treatment and prevention of HIV infection: 2nd expert panel meeting
  WHO consultation (2-4 May 2012, Geneva, Switzerland)
  4 May 2012
• WHO expert meeting on short-term HIV diagnosis, treatment initiation and monitoring technologies and approaches
  Meeting report (3-14 October 2011, Geneva, Switzerland)
  1 May 2012
• Retention in HIV programmes: Defining the challenges and identifying solutions
  Meeting report (13-15 September 2011, Geneva, Switzerland)
  1 May 2012
• Use of devices for adult male circumcision in public health HIV prevention programmes:
  Conclusions of the WHO Technical Advisory Group on Innovations in Male Circumcision - Executive summary
  29 February 2012
• Global forecasts of antiretroviral demand 2012-2013
  Joint WHO/UNAIDS consultation with pharmaceutical companies and stakeholders
  1 February 2012

2011

• The strategic use of antiretrovirals for treatment and prevention of HIV infection
  Report of a WHO technical consultation (14-16 November 2011)
  16 November 2011
• Short-term priorities for antiretroviral drug optimization
  Meeting report (18 – 19 April 2011, London, UK)
  15 July 2011

2009 - 2010

• Report of a consultation: preparing for pre-exposure prophylaxis (PrEP) results: from research to implementation.
  14 July 2010

2001 - 2008

• WHO Three 'I's meeting: intensified case finding, isoniazid preventive therapy and TB infection control for people living with HIV
  14 November 2008
• Paediatric HIV/antiretroviral therapy and care guideline review
  10 April 2008
• WHO consultation on ART failure in the context of a public health approach
  29 February 2008
• Prioritizing second-line antiretroviral drugs for adults and adolescents: a public health approach
  22 May 2007
• New data on male circumcision and HIV prevention: Policy and programme implications
  9 March 2007
• Treat, Train, Retain
  5 October 2006
• WHO recommendations for clinical mentoring to support scale-up of HIV care, antiretroviral therapy and prevention in resource-constrained settings
  7 August 2006
• WHO Expert Consultation on Cotrimoxazole Prophylaxis in HIV Infection
  7 March 2006
• Core competencies: Results from the International Consensus Meeting in HIV Service Delivery Training and Certification
  3 November 2005
• WHO consultation on technical and operational recommendations for scale-up of laboratory services and monitoring HIV antiretroviral therapy in resource-limited settings
  13 September 2005
• Standards for quality HIV care: a tool for quality assessment, improvement, and accreditation
  30 November 2004
• Ethics and equitable access to treatment and care for HIV/AIDS
  5 October 2004
• Malaria and HIV/AIDS interactions and implications
  6 July 2004
• New strategies for HIV/AIDS surveillance in resource-constrained countries
  4 July 2004
• Malaria and HIV interactions and their implications for public health policy
  25 June 2004
• Emergency scale-up of antiretroviral therapy in resource-limited settings: Technical and operational recommendations to achieve 3 by 5
  9 December 2003
• Partnership work: the health service-community interface for the prevention, care and treatment of HIV/AIDS
  30 November 2003
• Increasing access to HIV testing and counselling
  1 September 2003
• Strategic approaches to the prevention of HIV infection in infants
  1 September 2003
• Estimation of the incidence and prevalence of sexually transmitted infections
  5 December 2002
• Prevention of mother-to-child transmission of HIV: use of Nevirapine among women of unknown serostatus
  1 July 2002
• Improving access to care in developing countries: lessons from practice, research, resources and partnerships
  15 December 2001
• Herpes Simplex Virus Type 2: Programmatic and research priorities in developing countries
  23 May 2001